Literature DB >> 3855975

Primary central nervous system lymphoma.

Y Kawakami, K Tabuchi, R Ohnishi, S Asari, A Nishimoto.   

Abstract

A retrospective analysis of 21 cases of primary central nervous system (CNS) lymphoma is reported. All patients presented with a solitary mass in the supratentorial region. None had previously received immunosuppressive therapy. Neuroradiological studies included technetium-99m-pertechnetate brain scanning in eight cases, cerebral arteriography in all 21 cases, and computerized tomography (CT) in 14 cases. The characteristic features were increased uptake in brain scans, mass effect in arteriograms, and marked contrast enhancement on CT scans. Abnormal tumor vessels were occasionally seen on arteriography, and subtraction films were usually required to appreciate tumor stain. All patients underwent craniotomy, and histological studies of the tumors showed a diffuse type of lymphoma in all cases. Immunoglobulin testing was performed in 19 cases and a monoclonal spike was verified in 10, suggesting a B cell origin. All patients were followed until their death except one who was still alive 12 months from onset of symptoms. Therapy included subtotal resection in all 21 cases, whole-brain irradiation in six cases, chemotherapy in two cases, and a combination of whole-brain irradiation and chemotherapy in nine cases. Three different forms of chemotherapy were used. The results suggest that chemotherapy is an important addition to subtotal resection and whole-brain irradiation in the treatment of primary CNS lymphoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855975     DOI: 10.3171/jns.1985.62.4.0522

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain.

Authors:  M Watanabe; R Tanaka; N Takeda; K Wakabayashi; H Takahashi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 2.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

3.  Non-Hodgkin's lymphoma involving the brain. Diagnostic usefulness of stereotactic needle biopsy in combination with paraffin-section immunohistochemistry.

Authors:  H Nakamine; H Yokote; T Itakura; S Hayashi; N Komai; Y Takano; K Saito; H Moriwaki; E Nishino; T Takenaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Primary intracerebral Hodgkin's lymphoma.

Authors:  T P Doorly; M A Farrell; J Phillips
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

Review 5.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  Primary cranial vault lymphoma mimicking meningioma.

Authors:  A Isla; F Alvarez; M Gutiérrez; C Gamallo; M García-Blázquez; A Vega
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

7.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Primary central nervous system involvement of the so called 'peripheral T-cell lymphoma'. Report of a case and review of the literature.

Authors:  K Mineura; J Sawataishi; T Sasajima; M Kowada; A Sugawara; K Ebina
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

Review 10.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.